Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$263,874
-$334,722 QoQ
Shares Held
220
-60.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#4,254
of 4,605 holders
Holding Since
Sep 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cynosure Group, LLC holds $1,685,762 across 3 Drug Manufacturers - General names. LLY ranks #3 (15.7% of the industry book) .
All Filings in LLY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $263,874 | 220 | Shares | Sole | 2026-08-05 | |
| 2025-12-31 | $598,596 | 557 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $1,038,443 | 1,361 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,585,564 | 2,034 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,376,791 | 1,667 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,204,320 | 1,560 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,879,964 | 2,122 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,578,077 | 1,743 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,343,536 | 1,727 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $554,939 | 952 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $476,971 | 888 | Shares | Sole | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||